Fresenius SE Raises Guidance After Strong Kabi, Helios Performances
The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at Helios. Continue reading View comments
There is no Profile data available for FRE.BE.
33.25 | |
32.77 | |
- | |
33.34 | |
32.77 | |
24.38-36.11 | |
22 654 M | |
0 | |
0 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
The healthcare company lifted its full-year guidance after a robust third quarter driven by Kabi and good organic growth at Helios. Continue reading View comments
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With thi...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: